Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma
Completed · Phase 2
Conditions studied: Brain and Central Nervous System Tumors
In brief
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die. Giving chemotherapy with peripheral stem cell or bone marrow transplant may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: This phase II trial is studying how well thiotepa followed by peripheral stem cell or bone marrow transplant works in treating patients with malignant glioma.
Key facts
- Study ID
- NCT00008008
- Run by
- Herbert Irving Comprehensive Cancer Center
- People needed
- 40
- Starts
- 1997-09-01
- Expected to finish
- 2008-05-01
- Last updated by the study team
- 2013-02-04
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Joseph's Hospital and Medical Center — Paterson, New Jersey, United States
- Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.